PHAR Pharming Group NV Net earnings per share growth forecast for next year
Pharming Group N.V. (PHAR) maintains a stable cash flow driven by its monopoly status and high margins on orphan drugs, fueling the active global expansion of its product portfolio. The forward-looking earnings per share growth forecast confirms this trend, with this metric standing at 3.40. Completing the picture are innovations in recombinant proteins for the therapy of complex genetic pathologies.
Pharming Group - analytical breakdowns and key metrics (PHAR)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Pharming Group N.V.|PHAR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Pharming Group NV|PHAR - Company Aggregate Debts|Debt to Book Capitalization Ratio Pharming|PHAR - Company Long-Term Loans and Borrowings|Company Short-Term Debt Pharming Group|Quick Ratio pharming.com
- earnings and valuation multiples information:
PHAR - Net Financial Result|Expected Profit Pharming Group N.V.|PHAR - Price to Earnings Multiple|Forward P/E Multiple pharming.com|PHAR - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Pharming|PHAR - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Pharming Group|PHAR - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months pharming.com|PHAR - Earnings per share increase in current year|Net earnings per share growth forecast for next year Pharming Group N.V.
- total revenue and sales volume data:
Basic company analysis:PHAR, Pharming Group N.V.
This indicator measures the expected earnings per share (EPS) dynamics, assessing the business's ability to maintain profitability during shifts in technological cycles. By analyzing the chart of expected EPS growth for Pharming Group N.V. (PHAR) for the coming year, an investor can see the sensitivity of valuations to external shocks, which is critical for Pharming Group N.V. (PHAR) due to risks of biosample logistics disruptions and restricted access to global research resulting from geopolitical fragmentation.
Competitor analysis for Pharming Group N.V.
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|NKTR (Nektar Therapeutics) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth forecast for next year|Expected net earnings per share growth next year Immunome Corp IMNM|Expected earnings per share growth for next year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year SEPN (septerna.com)|Earnings growth forecast for next year pieris.com PVLA|SVRA: Expected earnings per share growth for next year|Rigel Pharmaceuticals, Inc. (RIGL) - Expected earnings per share growth for next year|ANAB: Earnings growth forecast for next year|Astria Corp (ATXS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year enGene|Earnings growth forecast for next year RAPT Therapeutics|Earnings growth forecast for next year JBIO|ACRS: Net earnings per share change forecast for next year|Earnings growth forecast for next year KYTX (kyvernatx.com)|TLSA - Expected earnings per share growth for next year|CABA - Net earnings per share growth forecast for next year|Ventyx Biosciences (VTYX) - Expected earnings per share growth for next year|Theratechnologies, Inc. (THTX) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth forecast for next year|Agenus, Inc (AGEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year CLYM|ZURA (Zura Bio Limited) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aTyr Pharma ATYR|ADAG - Expected earnings per share growth for next year|IMA - Net earnings per share growth forecast for next year|Shattuck Labs - Projected earnings per share increase next year|EQ: Earnings growth forecast for next year|Net earnings per share change forecast for next year CNTB (Connect Biopharma Holdings)|Expected earnings per share growth for next year IMUX|ATRA (atarabio.com) - Projected earnings per share increase next year|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharma (XFOR)|Adicet Bio Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year celularity.com CELU|INMB: Expected earnings per share growth for next year|BRNS: Net earnings per share growth forecast for next year|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc - Expected earnings per share trend next year|AKTX (Akari Therapeutics, Plc) - Earnings growth forecast for next year|ENLV: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Q32 Bio (QTTB)|Expected earnings per share growth for next year GeoVax Labs GOVX|Earnings growth forecast for next year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Expected net earnings per share growth next year|CARM: Expected earnings per share growth for next year|XTL Biopharmaceuticals (XTLB) - Expected earnings per share growth for next year|BOLT: Earnings growth forecast for next year|Expected earnings per share growth for next year HCW Biologics Inc.|Net earnings per share growth forecast for next year aptevotherapeutics.com|AIM: Expected earnings per share trend next year|Net earnings per share growth forecast for next year aditxt.com (ADTX)|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Expected net earnings per share growth next year|REVB - Net earnings per share growth forecast for next year|INDP - Earnings growth forecast for next year|SCNI: Earnings growth forecast for next year|Expected earnings per share growth for next year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth forecast for next year|allakos.com (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
